Global X FTSE Andean 40 ETF AND
Set alert
No live quote for AND yet.
- Open
- 0.00
- Prev close
- 16.27
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.27
- High
- 16.27
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.00
- 200-d avg
- 1.00
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 1.00
- 200-day average
- 1.00
Next earnings
Consensus EPS estimate 0.00.
News
- Teva Pharmaceuticals International Granted Exclusive Rights To Commercialize Formulations For Polpharma Biologics’ Proposed Biosimilar To Ocrevus
- Teva Pharma And Polpharma Biologics Announce Global Licensing Agreement Granting Teva Exclusive Rights To Commercialize Both Formulations Of Polpharma Biologics’ Proposed Biosimilar To Ocrevus, Upon Regulatory Approval
- Teva Pharmaceutical Industries Subsidiary And Medincell Says European Medicines Agency Has Accepted The Marketing Authorization Application For Olanzapine Long-Acting Injectable (TEV-'749) For The Treatment Of Schizophrenia In Adults
- New Kids On The Block: Global X's Top New ETFs
- Five Multi-Country EM ETFs To Consider
Your note
Sign in to keep a note on AND — it syncs with the Stock Master app.